WO2005115535A2 - Treating a tumor or the like with electric fields at different frequencies - Google Patents
Treating a tumor or the like with electric fields at different frequencies Download PDFInfo
- Publication number
- WO2005115535A2 WO2005115535A2 PCT/IB2005/002410 IB2005002410W WO2005115535A2 WO 2005115535 A2 WO2005115535 A2 WO 2005115535A2 IB 2005002410 W IB2005002410 W IB 2005002410W WO 2005115535 A2 WO2005115535 A2 WO 2005115535A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- khz
- electric fields
- electric field
- frequency
- target region
- Prior art date
Links
- 230000005684 electric field Effects 0.000 title claims abstract description 190
- 206010028980 Neoplasm Diseases 0.000 title description 81
- 230000006378 damage Effects 0.000 claims abstract description 46
- 230000032823 cell division Effects 0.000 claims abstract description 22
- 230000031016 anaphase Effects 0.000 claims abstract description 8
- 230000016853 telophase Effects 0.000 claims abstract description 7
- 238000000034 method Methods 0.000 claims description 60
- 230000012010 growth Effects 0.000 claims description 11
- 239000011248 coating agent Substances 0.000 claims description 9
- 238000000576 coating method Methods 0.000 claims description 9
- 230000002401 inhibitory effect Effects 0.000 claims description 6
- 210000004027 cell Anatomy 0.000 abstract description 213
- 210000004881 tumor cell Anatomy 0.000 abstract description 19
- 210000001519 tissue Anatomy 0.000 description 76
- 239000004020 conductor Substances 0.000 description 61
- 238000011282 treatment Methods 0.000 description 46
- 230000000694 effects Effects 0.000 description 36
- 239000000499 gel Substances 0.000 description 33
- 239000012528 membrane Substances 0.000 description 33
- 239000000463 material Substances 0.000 description 32
- 230000007246 mechanism Effects 0.000 description 22
- 230000008569 process Effects 0.000 description 19
- 238000009826 distribution Methods 0.000 description 18
- 230000015556 catabolic process Effects 0.000 description 16
- 210000000170 cell membrane Anatomy 0.000 description 14
- 238000010438 heat treatment Methods 0.000 description 14
- 201000001441 melanoma Diseases 0.000 description 13
- 239000000523 sample Substances 0.000 description 13
- 230000001965 increasing effect Effects 0.000 description 12
- 150000002500 ions Chemical class 0.000 description 12
- 210000000056 organ Anatomy 0.000 description 12
- 210000003463 organelle Anatomy 0.000 description 12
- 238000009413 insulation Methods 0.000 description 11
- 208000032612 Glial tumor Diseases 0.000 description 10
- 206010018338 Glioma Diseases 0.000 description 10
- 239000000853 adhesive Substances 0.000 description 10
- 230000006870 function Effects 0.000 description 10
- 210000000481 breast Anatomy 0.000 description 9
- 239000003990 capacitor Substances 0.000 description 9
- 210000000805 cytoplasm Anatomy 0.000 description 9
- 230000001070 adhesive effect Effects 0.000 description 8
- 230000015572 biosynthetic process Effects 0.000 description 8
- 210000000349 chromosome Anatomy 0.000 description 8
- 210000003722 extracellular fluid Anatomy 0.000 description 8
- 230000008901 benefit Effects 0.000 description 7
- 201000011510 cancer Diseases 0.000 description 7
- 230000001419 dependent effect Effects 0.000 description 7
- 238000009422 external insulation Methods 0.000 description 7
- 239000012212 insulator Substances 0.000 description 7
- 238000009421 internal insulation Methods 0.000 description 7
- 210000005061 intracellular organelle Anatomy 0.000 description 7
- 230000004936 stimulating effect Effects 0.000 description 7
- 241000894006 Bacteria Species 0.000 description 6
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 6
- 230000007423 decrease Effects 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 6
- 230000002147 killing effect Effects 0.000 description 6
- 230000003902 lesion Effects 0.000 description 6
- 230000001681 protective effect Effects 0.000 description 6
- 238000010276 construction Methods 0.000 description 5
- 239000013078 crystal Substances 0.000 description 5
- 239000011810 insulating material Substances 0.000 description 5
- 229920002521 macromolecule Polymers 0.000 description 5
- 230000035755 proliferation Effects 0.000 description 5
- 230000005855 radiation Effects 0.000 description 5
- 238000010408 sweeping Methods 0.000 description 5
- 238000012404 In vitro experiment Methods 0.000 description 4
- 210000004718 centriole Anatomy 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 238000002512 chemotherapy Methods 0.000 description 4
- 238000003776 cleavage reaction Methods 0.000 description 4
- 239000007822 coupling agent Substances 0.000 description 4
- 238000010586 diagram Methods 0.000 description 4
- 238000006073 displacement reaction Methods 0.000 description 4
- 238000005868 electrolysis reaction Methods 0.000 description 4
- 238000007917 intracranial administration Methods 0.000 description 4
- 230000003211 malignant effect Effects 0.000 description 4
- 229910052751 metal Inorganic materials 0.000 description 4
- 239000002184 metal Substances 0.000 description 4
- 210000004940 nucleus Anatomy 0.000 description 4
- 230000009467 reduction Effects 0.000 description 4
- 230000007017 scission Effects 0.000 description 4
- 230000035945 sensitivity Effects 0.000 description 4
- 208000026310 Breast neoplasm Diseases 0.000 description 3
- 108091060290 Chromatid Proteins 0.000 description 3
- 241000195493 Cryptophyta Species 0.000 description 3
- 241000233866 Fungi Species 0.000 description 3
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 3
- 102000029749 Microtubule Human genes 0.000 description 3
- 108091022875 Microtubule Proteins 0.000 description 3
- 241000699666 Mus <mouse, genus> Species 0.000 description 3
- 238000013459 approach Methods 0.000 description 3
- 210000003169 central nervous system Anatomy 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 210000004756 chromatid Anatomy 0.000 description 3
- 230000000295 complement effect Effects 0.000 description 3
- 238000007796 conventional method Methods 0.000 description 3
- 230000001351 cycling effect Effects 0.000 description 3
- 230000021953 cytokinesis Effects 0.000 description 3
- 239000007933 dermal patch Substances 0.000 description 3
- 238000010291 electrical method Methods 0.000 description 3
- 238000004520 electroporation Methods 0.000 description 3
- 239000004744 fabric Substances 0.000 description 3
- 239000000835 fiber Substances 0.000 description 3
- 238000007667 floating Methods 0.000 description 3
- 238000001727 in vivo Methods 0.000 description 3
- 210000004688 microtubule Anatomy 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 230000003287 optical effect Effects 0.000 description 3
- 230000037361 pathway Effects 0.000 description 3
- 230000000149 penetrating effect Effects 0.000 description 3
- 239000004033 plastic Substances 0.000 description 3
- 229920003023 plastic Polymers 0.000 description 3
- 230000031877 prophase Effects 0.000 description 3
- 238000001959 radiotherapy Methods 0.000 description 3
- 230000000638 stimulation Effects 0.000 description 3
- 206010006187 Breast cancer Diseases 0.000 description 2
- -1 Ca++ ions Chemical class 0.000 description 2
- 201000009030 Carcinoma Diseases 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 241000204031 Mycoplasma Species 0.000 description 2
- 206010029098 Neoplasm skin Diseases 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- 208000000453 Skin Neoplasms Diseases 0.000 description 2
- 238000002679 ablation Methods 0.000 description 2
- 208000009956 adenocarcinoma Diseases 0.000 description 2
- 210000004102 animal cell Anatomy 0.000 description 2
- 239000002246 antineoplastic agent Substances 0.000 description 2
- 229910002113 barium titanate Inorganic materials 0.000 description 2
- 230000000747 cardiac effect Effects 0.000 description 2
- 239000000919 ceramic Substances 0.000 description 2
- 229940127089 cytotoxic agent Drugs 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 208000035475 disorder Diseases 0.000 description 2
- 239000013013 elastic material Substances 0.000 description 2
- 239000003792 electrolyte Substances 0.000 description 2
- 210000003527 eukaryotic cell Anatomy 0.000 description 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 2
- 239000010931 gold Substances 0.000 description 2
- 229910052737 gold Inorganic materials 0.000 description 2
- 239000000017 hydrogel Substances 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 230000016507 interphase Effects 0.000 description 2
- 230000003834 intracellular effect Effects 0.000 description 2
- 210000002977 intracellular fluid Anatomy 0.000 description 2
- 230000000670 limiting effect Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- GQYHUHYESMUTHG-UHFFFAOYSA-N lithium niobate Chemical compound [Li+].[O-][Nb](=O)=O GQYHUHYESMUTHG-UHFFFAOYSA-N 0.000 description 2
- 201000005202 lung cancer Diseases 0.000 description 2
- 208000020816 lung neoplasm Diseases 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 230000011278 mitosis Effects 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 230000036961 partial effect Effects 0.000 description 2
- 230000037368 penetrate the skin Effects 0.000 description 2
- 230000000737 periodic effect Effects 0.000 description 2
- 230000010076 replication Effects 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 208000037803 restenosis Diseases 0.000 description 2
- 230000000717 retained effect Effects 0.000 description 2
- 231100000241 scar Toxicity 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 238000007493 shaping process Methods 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- 210000001550 testis Anatomy 0.000 description 2
- 239000004408 titanium dioxide Substances 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 230000001052 transient effect Effects 0.000 description 2
- 210000003708 urethra Anatomy 0.000 description 2
- 210000001215 vagina Anatomy 0.000 description 2
- 230000002792 vascular Effects 0.000 description 2
- WSMQKESQZFQMFW-UHFFFAOYSA-N 5-methyl-pyrazole-3-carboxylic acid Chemical compound CC1=CC(C(O)=O)=NN1 WSMQKESQZFQMFW-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 201000003076 Angiosarcoma Diseases 0.000 description 1
- 206010003571 Astrocytoma Diseases 0.000 description 1
- 206010004146 Basal cell carcinoma Diseases 0.000 description 1
- 206010004446 Benign prostatic hyperplasia Diseases 0.000 description 1
- 206010004593 Bile duct cancer Diseases 0.000 description 1
- 206010005003 Bladder cancer Diseases 0.000 description 1
- 208000003174 Brain Neoplasms Diseases 0.000 description 1
- 206010006784 Burning sensation Diseases 0.000 description 1
- 206010008342 Cervix carcinoma Diseases 0.000 description 1
- 208000005243 Chondrosarcoma Diseases 0.000 description 1
- 201000009047 Chordoma Diseases 0.000 description 1
- 208000006332 Choriocarcinoma Diseases 0.000 description 1
- 208000032544 Cicatrix Diseases 0.000 description 1
- 206010009944 Colon cancer Diseases 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 208000009798 Craniopharyngioma Diseases 0.000 description 1
- 208000002699 Digestive System Neoplasms Diseases 0.000 description 1
- 201000009051 Embryonal Carcinoma Diseases 0.000 description 1
- 206010014967 Ependymoma Diseases 0.000 description 1
- 208000006168 Ewing Sarcoma Diseases 0.000 description 1
- 201000008808 Fibrosarcoma Diseases 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 208000001258 Hemangiosarcoma Diseases 0.000 description 1
- 208000018142 Leiomyosarcoma Diseases 0.000 description 1
- 229910003327 LiNbO3 Inorganic materials 0.000 description 1
- 206010025323 Lymphomas Diseases 0.000 description 1
- 208000007054 Medullary Carcinoma Diseases 0.000 description 1
- 208000000172 Medulloblastoma Diseases 0.000 description 1
- 206010027406 Mesothelioma Diseases 0.000 description 1
- 206010027476 Metastases Diseases 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 206010029260 Neuroblastoma Diseases 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 201000010133 Oligodendroglioma Diseases 0.000 description 1
- 206010033128 Ovarian cancer Diseases 0.000 description 1
- 206010061535 Ovarian neoplasm Diseases 0.000 description 1
- 206010061902 Pancreatic neoplasm Diseases 0.000 description 1
- 208000007641 Pinealoma Diseases 0.000 description 1
- 206010035226 Plasma cell myeloma Diseases 0.000 description 1
- 208000007452 Plasmacytoma Diseases 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 208000006994 Precancerous Conditions Diseases 0.000 description 1
- 206010060862 Prostate cancer Diseases 0.000 description 1
- 208000004403 Prostatic Hyperplasia Diseases 0.000 description 1
- 208000000236 Prostatic Neoplasms Diseases 0.000 description 1
- 201000004681 Psoriasis Diseases 0.000 description 1
- 208000006265 Renal cell carcinoma Diseases 0.000 description 1
- 201000000582 Retinoblastoma Diseases 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 206010039491 Sarcoma Diseases 0.000 description 1
- 201000010208 Seminoma Diseases 0.000 description 1
- 208000024313 Testicular Neoplasms Diseases 0.000 description 1
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 1
- 208000014070 Vestibular schwannoma Diseases 0.000 description 1
- 208000008383 Wilms tumor Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 208000004064 acoustic neuroma Diseases 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 238000002399 angioplasty Methods 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 238000003491 array Methods 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 210000003050 axon Anatomy 0.000 description 1
- JRPBQTZRNDNNOP-UHFFFAOYSA-N barium titanate Chemical compound [Ba+2].[Ba+2].[O-][Ti]([O-])([O-])[O-] JRPBQTZRNDNNOP-UHFFFAOYSA-N 0.000 description 1
- 201000007180 bile duct carcinoma Diseases 0.000 description 1
- 201000001531 bladder carcinoma Diseases 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 210000005013 brain tissue Anatomy 0.000 description 1
- 208000003362 bronchogenic carcinoma Diseases 0.000 description 1
- 230000003047 cage effect Effects 0.000 description 1
- 238000010888 cage effect Methods 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 210000002230 centromere Anatomy 0.000 description 1
- 201000010881 cervical cancer Diseases 0.000 description 1
- 239000013043 chemical agent Substances 0.000 description 1
- 239000013611 chromosomal DNA Substances 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000011231 conductive filler Substances 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 208000035250 cutaneous malignant susceptibility to 1 melanoma Diseases 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 208000002445 cystadenocarcinoma Diseases 0.000 description 1
- 239000003989 dielectric material Substances 0.000 description 1
- 238000004720 dielectrophoresis Methods 0.000 description 1
- NKZSPGSOXYXWQA-UHFFFAOYSA-N dioxido(oxo)titanium;lead(2+) Chemical compound [Pb+2].[O-][Ti]([O-])=O NKZSPGSOXYXWQA-UHFFFAOYSA-N 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000008151 electrolyte solution Substances 0.000 description 1
- 210000002889 endothelial cell Anatomy 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 208000037828 epithelial carcinoma Diseases 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 230000005669 field effect Effects 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 229920001821 foam rubber Polymers 0.000 description 1
- 239000002223 garnet Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 238000001415 gene therapy Methods 0.000 description 1
- 210000003313 haploid nucleated cell Anatomy 0.000 description 1
- 210000005003 heart tissue Anatomy 0.000 description 1
- 230000017525 heat dissipation Effects 0.000 description 1
- 201000002222 hemangioblastoma Diseases 0.000 description 1
- 206010073071 hepatocellular carcinoma Diseases 0.000 description 1
- 230000003463 hyperproliferative effect Effects 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- MTRJKZUDDJZTLA-UHFFFAOYSA-N iron yttrium Chemical compound [Fe].[Y] MTRJKZUDDJZTLA-UHFFFAOYSA-N 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 208000011379 keloid formation Diseases 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- 206010024627 liposarcoma Diseases 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 201000005296 lung carcinoma Diseases 0.000 description 1
- 208000037829 lymphangioendotheliosarcoma Diseases 0.000 description 1
- 208000012804 lymphangiosarcoma Diseases 0.000 description 1
- 230000036244 malformation Effects 0.000 description 1
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 208000023356 medullary thyroid gland carcinoma Diseases 0.000 description 1
- 230000021121 meiosis Effects 0.000 description 1
- 206010027191 meningioma Diseases 0.000 description 1
- 230000031864 metaphase Effects 0.000 description 1
- 208000037819 metastatic cancer Diseases 0.000 description 1
- 208000011575 metastatic malignant neoplasm Diseases 0.000 description 1
- 230000037230 mobility Effects 0.000 description 1
- 201000000050 myeloid neoplasm Diseases 0.000 description 1
- 210000001087 myotubule Anatomy 0.000 description 1
- 208000001611 myxosarcoma Diseases 0.000 description 1
- 208000025189 neoplasm of testis Diseases 0.000 description 1
- 210000004126 nerve fiber Anatomy 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 201000008968 osteosarcoma Diseases 0.000 description 1
- 238000013021 overheating Methods 0.000 description 1
- ZBSCCQXBYNSKPV-UHFFFAOYSA-N oxolead;oxomagnesium;2,4,5-trioxa-1$l^{5},3$l^{5}-diniobabicyclo[1.1.1]pentane 1,3-dioxide Chemical compound [Mg]=O.[Pb]=O.[Pb]=O.[Pb]=O.O1[Nb]2(=O)O[Nb]1(=O)O2 ZBSCCQXBYNSKPV-UHFFFAOYSA-N 0.000 description 1
- 201000002528 pancreatic cancer Diseases 0.000 description 1
- 208000008443 pancreatic carcinoma Diseases 0.000 description 1
- 208000004019 papillary adenocarcinoma Diseases 0.000 description 1
- 201000010198 papillary carcinoma Diseases 0.000 description 1
- 230000003071 parasitic effect Effects 0.000 description 1
- 230000000849 parathyroid Effects 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 210000000578 peripheral nerve Anatomy 0.000 description 1
- 208000024724 pineal body neoplasm Diseases 0.000 description 1
- 201000004123 pineal gland cancer Diseases 0.000 description 1
- 230000010287 polarization Effects 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000012191 relaxation of muscle Effects 0.000 description 1
- 201000009410 rhabdomyosarcoma Diseases 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000037387 scars Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 201000008407 sebaceous adenocarcinoma Diseases 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 208000000587 small cell lung carcinoma Diseases 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 206010041823 squamous cell carcinoma Diseases 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 201000010965 sweat gland carcinoma Diseases 0.000 description 1
- 230000001360 synchronised effect Effects 0.000 description 1
- 206010042863 synovial sarcoma Diseases 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 201000003120 testicular cancer Diseases 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 210000001685 thyroid gland Anatomy 0.000 description 1
- 230000008467 tissue growth Effects 0.000 description 1
- 230000000472 traumatic effect Effects 0.000 description 1
- 210000005239 tubule Anatomy 0.000 description 1
- 230000004614 tumor growth Effects 0.000 description 1
- 230000004222 uncontrolled growth Effects 0.000 description 1
- 208000010570 urinary bladder carcinoma Diseases 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/326—Applying electric currents by contact electrodes alternating or intermittent currents for promoting growth of cells, e.g. bone cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/40—Applying electric fields by inductive or capacitive coupling ; Applying radio-frequency signals
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Radiology & Medical Imaging (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Cell Biology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Electrotherapy Devices (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
Abstract
Description
Claims
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200580018206.6A CN1976738B (en) | 2004-04-23 | 2005-04-21 | Treating a tumor or the like with an electric field |
CA2563817A CA2563817C (en) | 2004-04-23 | 2005-04-21 | Treating a tumor or the like with electric fields at different frequencies |
JP2007509012A JP4750784B2 (en) | 2004-04-23 | 2005-04-21 | Treatment of tumors by electric fields of different frequencies |
EP05767642A EP1740268A2 (en) | 2004-04-23 | 2005-04-21 | Treating a tumor or the like with electric fields at different frequencies |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US56506504P | 2004-04-23 | 2004-04-23 | |
US60/565,065 | 2004-04-23 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2005115535A2 true WO2005115535A2 (en) | 2005-12-08 |
WO2005115535A3 WO2005115535A3 (en) | 2006-04-06 |
Family
ID=35240980
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB2005/002410 WO2005115535A2 (en) | 2004-04-23 | 2005-04-21 | Treating a tumor or the like with electric fields at different frequencies |
Country Status (6)
Country | Link |
---|---|
US (5) | US7599745B2 (en) |
EP (1) | EP1740268A2 (en) |
JP (2) | JP4750784B2 (en) |
CN (1) | CN1976738B (en) |
CA (1) | CA2563817C (en) |
WO (1) | WO2005115535A2 (en) |
Cited By (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009036468A1 (en) * | 2007-09-14 | 2009-03-19 | Lazure Technologies, Llc | Transurethral systems and methods for ablation treatment of prostate tissue |
WO2019084003A1 (en) * | 2017-10-23 | 2019-05-02 | Cardiac Pacemakers, Inc. | Medical devices for cancer therapy with electric field shaping elements |
WO2020219339A1 (en) * | 2019-04-22 | 2020-10-29 | Boston Scientific Scimed, Inc. | Combination electrical and chemotherapeutic treatment of cancer |
WO2020219519A1 (en) * | 2019-04-23 | 2020-10-29 | Boston Scientific Scimed, Inc. | Electrodes for electrical stimulation to treat cancer |
EP3895758A1 (en) * | 2018-07-03 | 2021-10-20 | Edwin Chang | Using alternating electric fields to increase cell membrane permeability |
WO2022144686A1 (en) * | 2020-12-30 | 2022-07-07 | Novocure Gmbh | Method and apparatus for determining transducer locations to generate tumor treating fields |
US11420049B2 (en) | 2019-04-22 | 2022-08-23 | Boston Scientific Scimed, Inc. | Systems for administering electrical stimulation to treat cancer |
WO2022122445A3 (en) * | 2020-12-11 | 2022-08-25 | Tdk Electronics Ag | Ceramic electrode, assembly comprising the ceramic electrode, arrangement comprising the ceramic electrode, and method for producing a ceramic electrode |
US11607542B2 (en) | 2019-04-23 | 2023-03-21 | Boston Scientific Scimed, Inc. | Electrical stimulation for cancer treatment with internal and external electrodes |
US11654279B2 (en) | 2019-07-31 | 2023-05-23 | Novocure Gmbh | Applying tumor treating fields (TTFields) via electrodes embedded into skull implants |
US11691006B2 (en) | 2019-04-22 | 2023-07-04 | Boston Scientific Scimed, Inc. | Electrical stimulation devices for cancer treatment |
US11712561B2 (en) | 2019-04-23 | 2023-08-01 | Boston Scientific Scimed, Inc. | Electrical stimulation with thermal treatment or thermal monitoring |
US11730956B2 (en) | 2018-05-23 | 2023-08-22 | Ricoh Company, Ltd. | Power supply apparatus and magnetic field generation system |
US11883655B2 (en) | 2020-02-24 | 2024-01-30 | Boston Scientific Scimed, Inc. | Systems and methods for treatment of pancreatic cancer |
US11938317B2 (en) | 2017-12-26 | 2024-03-26 | Galvanize Therapeutics, Inc. | Optimization of energy delivery for various applications |
WO2024062457A1 (en) * | 2022-09-23 | 2024-03-28 | Novocure Gmbh | Treating skin irritation from application of an alternating electric field |
Families Citing this family (243)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6104959A (en) | 1997-07-31 | 2000-08-15 | Microwave Medical Corp. | Method and apparatus for treating subcutaneous histological features |
US8175698B2 (en) | 2000-02-17 | 2012-05-08 | Novocure Ltd. | Treating bacteria with electric fields |
US7599745B2 (en) * | 2000-02-17 | 2009-10-06 | Standen Ltd | Treating a tumor or the like with an electric field |
US7599746B2 (en) | 2000-02-17 | 2009-10-06 | Standen Ltd | Apparatus and method for preventing the spread of cancerous metastases and for elimination of metastases |
CN1416466A (en) | 2000-02-17 | 2003-05-07 | 约朗姆·帕尔蒂 | Method and appts. for destroying dividing cells |
US6868289B2 (en) * | 2002-10-02 | 2005-03-15 | Standen Ltd. | Apparatus for treating a tumor or the like and articles incorporating the apparatus for treatment of the tumor |
US7565206B2 (en) * | 2000-02-17 | 2009-07-21 | Standen Ltd. | Treating a tumor or the like with electric fields at different orientations |
US8447395B2 (en) * | 2000-02-17 | 2013-05-21 | Novocure Ltd | Treating bacteria with electric fields |
US7136699B2 (en) * | 2002-10-02 | 2006-11-14 | Standen, Ltd. | Apparatus for destroying dividing cells |
US7089054B2 (en) * | 2002-10-02 | 2006-08-08 | Standen Ltd. | Apparatus and method for treating a tumor or the like |
US7756583B2 (en) | 2002-04-08 | 2010-07-13 | Ardian, Inc. | Methods and apparatus for intravascularly-induced neuromodulation |
US8175711B2 (en) | 2002-04-08 | 2012-05-08 | Ardian, Inc. | Methods for treating a condition or disease associated with cardio-renal function |
US9636174B2 (en) | 2002-04-08 | 2017-05-02 | Medtronic Ardian Luxembourg S.A.R.L. | Methods for therapeutic renal neuromodulation |
US8145317B2 (en) | 2002-04-08 | 2012-03-27 | Ardian, Inc. | Methods for renal neuromodulation |
US6978174B2 (en) | 2002-04-08 | 2005-12-20 | Ardian, Inc. | Methods and devices for renal nerve blocking |
US8131371B2 (en) | 2002-04-08 | 2012-03-06 | Ardian, Inc. | Methods and apparatus for monopolar renal neuromodulation |
US7162303B2 (en) | 2002-04-08 | 2007-01-09 | Ardian, Inc. | Renal nerve stimulation method and apparatus for treatment of patients |
US8774913B2 (en) | 2002-04-08 | 2014-07-08 | Medtronic Ardian Luxembourg S.A.R.L. | Methods and apparatus for intravasculary-induced neuromodulation |
US20080213331A1 (en) | 2002-04-08 | 2008-09-04 | Ardian, Inc. | Methods and devices for renal nerve blocking |
US20070129761A1 (en) | 2002-04-08 | 2007-06-07 | Ardian, Inc. | Methods for treating heart arrhythmia |
US7620451B2 (en) | 2005-12-29 | 2009-11-17 | Ardian, Inc. | Methods and apparatus for pulsed electric field neuromodulation via an intra-to-extravascular approach |
US7853333B2 (en) | 2002-04-08 | 2010-12-14 | Ardian, Inc. | Methods and apparatus for multi-vessel renal neuromodulation |
US8347891B2 (en) | 2002-04-08 | 2013-01-08 | Medtronic Ardian Luxembourg S.A.R.L. | Methods and apparatus for performing a non-continuous circumferential treatment of a body lumen |
US20070135875A1 (en) | 2002-04-08 | 2007-06-14 | Ardian, Inc. | Methods and apparatus for thermally-induced renal neuromodulation |
US20140018880A1 (en) | 2002-04-08 | 2014-01-16 | Medtronic Ardian Luxembourg S.A.R.L. | Methods for monopolar renal neuromodulation |
US9308043B2 (en) | 2002-04-08 | 2016-04-12 | Medtronic Ardian Luxembourg S.A.R.L. | Methods for monopolar renal neuromodulation |
US8150519B2 (en) | 2002-04-08 | 2012-04-03 | Ardian, Inc. | Methods and apparatus for bilateral renal neuromodulation |
US8774922B2 (en) | 2002-04-08 | 2014-07-08 | Medtronic Ardian Luxembourg S.A.R.L. | Catheter apparatuses having expandable balloons for renal neuromodulation and associated systems and methods |
US8145316B2 (en) | 2002-04-08 | 2012-03-27 | Ardian, Inc. | Methods and apparatus for renal neuromodulation |
US9308044B2 (en) | 2002-04-08 | 2016-04-12 | Medtronic Ardian Luxembourg S.A.R.L. | Methods for therapeutic renal neuromodulation |
US7653438B2 (en) | 2002-04-08 | 2010-01-26 | Ardian, Inc. | Methods and apparatus for renal neuromodulation |
US7617005B2 (en) | 2002-04-08 | 2009-11-10 | Ardian, Inc. | Methods and apparatus for thermally-induced renal neuromodulation |
US20040082859A1 (en) | 2002-07-01 | 2004-04-29 | Alan Schaer | Method and apparatus employing ultrasound energy to treat body sphincters |
DE10260149A1 (en) | 2002-12-20 | 2004-07-01 | BSH Bosch und Siemens Hausgeräte GmbH | Device for determining the conductivity of laundry, clothes dryer and method for preventing layer formation on electrodes |
TW200416015A (en) * | 2003-02-17 | 2004-09-01 | Wei-Gung Wang | Device for selectively generating hydrogen ions in an aqueous solution |
US7775087B2 (en) * | 2004-03-16 | 2010-08-17 | Northwestern University | Microchannel forming method and nanotipped dispensing device having a microchannel |
US20060047328A1 (en) * | 2004-08-31 | 2006-03-02 | Patrick Murphy | Multi-frequency electrical field generator and use thereof |
US7937143B2 (en) | 2004-11-02 | 2011-05-03 | Ardian, Inc. | Methods and apparatus for inducing controlled renal neuromodulation |
ES2344215T3 (en) * | 2004-12-07 | 2010-08-20 | Standen Ltd. | ELECTRODES TO APPLY A LIVE ELECTRIC FIELD DURING A DILATED TIME PERIOD. |
US20110160621A1 (en) * | 2005-06-24 | 2011-06-30 | Henry Nita | Methods and apparatus for dissolving intracranial blood clots |
US7717853B2 (en) * | 2005-06-24 | 2010-05-18 | Henry Nita | Methods and apparatus for intracranial ultrasound delivery |
EP2902075B1 (en) * | 2005-10-03 | 2022-11-16 | Novocure GmbH | Optimizing characteristics of an electric field to increase the field's effect on proliferating cells |
US8874227B2 (en) | 2009-03-20 | 2014-10-28 | ElectroCore, LLC | Devices and methods for non-invasive capacitive electrical stimulation and their use for vagus nerve stimulation on the neck of a patient |
US8019414B2 (en) | 2006-04-05 | 2011-09-13 | Novocure Ltd. | Treating cancer using electromagnetic fields in combination with other treatment regimens |
JP5457183B2 (en) * | 2006-09-14 | 2014-04-02 | ラジュール・テクノロジーズ・エルエルシイ | Apparatus and method for destroying cancer cells |
PT2167194T (en) * | 2007-03-06 | 2017-06-15 | Novocure Ltd | Treating cancer using electromagnetic fields in combination with photodynamic therapy |
RU2523620C2 (en) | 2007-04-19 | 2014-07-20 | Мирамар Лэбс,Инк. | Systems and methods for generating exposure on target tissue with using microwave energy |
WO2008131306A1 (en) | 2007-04-19 | 2008-10-30 | The Foundry, Inc. | Systems and methods for creating an effect using microwave energy to specified tissue |
EP2142129A4 (en) | 2007-04-19 | 2011-04-20 | Miramar Labs Inc | Methods and apparatus for reducing sweat production |
US9241763B2 (en) | 2007-04-19 | 2016-01-26 | Miramar Labs, Inc. | Systems, apparatus, methods and procedures for the noninvasive treatment of tissue using microwave energy |
EP2142125B1 (en) | 2007-04-19 | 2014-03-05 | Miramar Labs, Inc. | Devices, and systems for non-invasive delivery of microwave therapy |
CN101820947A (en) * | 2007-08-14 | 2010-09-01 | 诺沃库勒有限公司 | Use treating parasites with electric fields |
WO2009036459A1 (en) * | 2007-09-14 | 2009-03-19 | Lazure Technologies, Llc | Multi-tine probe and treatment by activation of opposing tines |
WO2009036457A1 (en) * | 2007-09-14 | 2009-03-19 | Lazure Technologies, Llc | Multi-layer electrode ablation probe and related methods |
ES2471971T3 (en) | 2007-12-12 | 2014-06-27 | Miramar Labs, Inc. | System and apparatus for non-invasive treatment of tissue using microwave energy |
AU2008335715B2 (en) | 2007-12-12 | 2014-01-23 | Miradry, Inc. | Systems, apparatus, methods and procedures for the noninvasive treatment of tissue using microwave energy |
US20100100093A1 (en) * | 2008-09-16 | 2010-04-22 | Lazure Technologies, Llc. | System and method for controlled tissue heating for destruction of cancerous cells |
US8652129B2 (en) | 2008-12-31 | 2014-02-18 | Medtronic Ardian Luxembourg S.A.R.L. | Apparatus, systems, and methods for achieving intravascular, thermally-induced renal neuromodulation |
EP2376011B1 (en) | 2009-01-09 | 2019-07-03 | ReCor Medical, Inc. | Apparatus for treatment of mitral valve insufficiency |
US8728139B2 (en) | 2009-04-16 | 2014-05-20 | Lazure Technologies, Llc | System and method for energy delivery to a tissue using an electrode array |
CN101628155B (en) * | 2009-08-14 | 2012-04-18 | 鞍山市嘉惠广播电子技术有限公司 | Ultrahigh frequency tumor treatment equipment |
US9375223B2 (en) | 2009-10-06 | 2016-06-28 | Cardioprolific Inc. | Methods and devices for endovascular therapy |
US20110209723A1 (en) * | 2010-03-01 | 2011-09-01 | David Hunt Sullivan | Methods Of Treating Clothing And Textiles And Articles Treated Thereby |
US9526911B1 (en) | 2010-04-27 | 2016-12-27 | Lazure Scientific, Inc. | Immune mediated cancer cell destruction, systems and methods |
US8719720B2 (en) | 2010-09-24 | 2014-05-06 | Honeywell International Inc. | Economizer controller plug and play system recognition with automatic user interface population |
JP6046041B2 (en) | 2010-10-25 | 2016-12-14 | メドトロニック アーディアン ルクセンブルク ソシエテ ア レスポンサビリテ リミテ | Devices, systems, and methods for neuromodulation therapy evaluation and feedback |
US9233257B1 (en) | 2010-11-22 | 2016-01-12 | Jacob Zabara | Electromagnetic radiation treatment |
US8684901B1 (en) | 2010-11-22 | 2014-04-01 | Jacob Zabara | Electromagnetic radiation treatment for cancer and pathological genetic regulations |
CA2826770C (en) | 2011-02-15 | 2020-06-23 | Hemosonics, Llc | Characterization of blood hemostasis and oxygen transport parameters |
US9901387B2 (en) | 2011-05-09 | 2018-02-27 | Innovolink, Llc | Apparatus and method for heating adipose cells |
US9901742B2 (en) * | 2011-05-09 | 2018-02-27 | Innovolink, Llc | Apparatus and method for heating a treatment region with an alternating electric field |
US20120290049A1 (en) * | 2011-05-09 | 2012-11-15 | Michel Marc | Apparatus and Method for Providing a Substantially Constant Voltage Between Electrodes Extending Across a Treatment Region |
US9675814B2 (en) | 2011-05-09 | 2017-06-13 | Innovolink, Llc | Apparatus and method for obtaining a substantially constant current across a treatment region |
US9956028B2 (en) | 2011-05-09 | 2018-05-01 | Innovolink, Llc | Apparatus and method for heating biological targets |
WO2012154736A1 (en) * | 2011-05-09 | 2012-11-15 | Innovolink, Llc | Apparatus and method for heating a treatment region with an alternating electric field |
US9314301B2 (en) | 2011-08-01 | 2016-04-19 | Miramar Labs, Inc. | Applicator and tissue interface module for dermatological device |
WO2013022939A1 (en) | 2011-08-08 | 2013-02-14 | Ruse Richard B | Method and apparatus for treating cancer |
US9486625B2 (en) | 2011-08-08 | 2016-11-08 | Medamp Electronics, Llc | Method for treating benign prostate hyperplasia |
CA2865242A1 (en) | 2012-03-08 | 2013-09-12 | Medtronic Ardian Luxembourg S.A.R.L. | Biomarker sampling in the context of neuromodulation devices and associated systems and methods |
US9750568B2 (en) | 2012-03-08 | 2017-09-05 | Medtronic Ardian Luxembourg S.A.R.L. | Ovarian neuromodulation and associated systems and methods |
WO2014039569A2 (en) | 2012-09-05 | 2014-03-13 | ElectroCore, LLC | Non-invasive vagal nerve stimulation to treat disorders |
US20140110296A1 (en) | 2012-10-19 | 2014-04-24 | Medtronic Ardian Luxembourg S.A.R.L. | Packaging for Catheter Treatment Devices and Associated Devices, Systems, and Methods |
US10080907B1 (en) | 2012-10-26 | 2018-09-25 | University Of South Florida | Systems and methods for controlling the spatial distribution of an electromagnetic field |
US10779875B2 (en) | 2013-05-06 | 2020-09-22 | Novocure Gmbh | Optimizing treatment using TTfields by changing the frequency during the course of long term tumor treatment |
US9655669B2 (en) | 2013-05-06 | 2017-05-23 | Novocure Limited | Optimizing treatment using TTFields by changing the frequency during the course of long term tumor treatment |
US10779885B2 (en) | 2013-07-24 | 2020-09-22 | Miradry. Inc. | Apparatus and methods for the treatment of tissue using microwave energy |
US9980766B1 (en) | 2014-03-28 | 2018-05-29 | Medtronic Ardian Luxembourg S.A.R.L. | Methods and systems for renal neuromodulation |
US10194979B1 (en) | 2014-03-28 | 2019-02-05 | Medtronic Ardian Luxembourg S.A.R.L. | Methods for catheter-based renal neuromodulation |
US10194980B1 (en) | 2014-03-28 | 2019-02-05 | Medtronic Ardian Luxembourg S.A.R.L. | Methods for catheter-based renal neuromodulation |
US20190117963A1 (en) | 2014-07-25 | 2019-04-25 | Loyalty Based Innovations, LLC | Apparatus and method for treating multiple tumors in patients with metastatic disease by electric fields |
US9833617B2 (en) * | 2014-07-25 | 2017-12-05 | Loyalty Based Innovations, LLC | Apparatus and method for treating multiple tumors in patients with metastatic disease by electric fields |
WO2016142176A1 (en) | 2015-03-09 | 2016-09-15 | Koninklijke Philips N.V. | Iontophoretic device, arrangement and method |
US9726647B2 (en) | 2015-03-17 | 2017-08-08 | Hemosonics, Llc | Determining mechanical properties via ultrasound-induced resonance |
US9910453B2 (en) | 2015-09-25 | 2018-03-06 | Novocure Limited | High voltage, high efficiency sine wave generator with pre-set frequency and adjustable amplitude |
US10188851B2 (en) | 2015-10-28 | 2019-01-29 | Novocure Limited | TTField treatment with optimization of electrode positions on the head based on MRI-based conductivity measurements |
US11571567B2 (en) * | 2016-01-05 | 2023-02-07 | Biosensor Laboratories Inc. | Iontophoresis device for drug delivery and method for manufacturing the same |
US10821283B2 (en) | 2016-04-04 | 2020-11-03 | Novocure Gmbh | Reducing motility of cancer cells using tumor treating fields (TTFields) |
EP4147747A1 (en) | 2016-06-30 | 2023-03-15 | Novocure GmbH | Arrays for longitudinal delivery of ttfields to a body |
EP3500334B1 (en) * | 2016-08-18 | 2023-08-09 | Novocure GmbH | Temperature measurement in arrays for delivering ttfields |
EP4302820A3 (en) | 2016-11-24 | 2024-03-06 | Public University Corporation Yokohama City University | Cancer treatment apparatus |
JP7184774B2 (en) | 2016-12-13 | 2022-12-06 | ノボキュア ゲーエムベーハー | Treat a patient with a TT field with electrode positions optimized using a deformable template |
EP3571503A1 (en) | 2017-01-19 | 2019-11-27 | Moshe Giladi | System for viewing cell cultures under a microscope whilst applying ttfields |
CN106823125A (en) * | 2017-03-24 | 2017-06-13 | 长沙利星医药科技开发有限公司 | A kind of device of use amplitude modulation electric-field enhancing curative effect of medication |
CN107281635B (en) * | 2017-07-26 | 2024-01-16 | 江苏海莱新创医疗科技有限公司 | Electrode physiotherapy device and electrode positioning method |
US20190117970A1 (en) * | 2017-10-23 | 2019-04-25 | Cardiac Pacemakers, Inc. | Electric field shaping leads for treatment of cancer |
US20190117969A1 (en) * | 2017-10-23 | 2019-04-25 | Cardiac Pacemakers, Inc. | Medical devices for treatment of cancer with electric fields |
US20220125510A1 (en) * | 2020-10-26 | 2022-04-28 | Evanesc Therapeutics, Inc. | Apparatus for application of evanescent waves to biological tissues |
CN111601641B (en) | 2017-11-07 | 2022-06-07 | 伊凡斯克医疗公司 | Device for treating tumors by evanescent waves |
CN110115803A (en) * | 2018-02-07 | 2019-08-13 | 张建义 | A kind of power supply device can be used for biomedical research and auxiliary electrode Array Design |
US10953209B2 (en) | 2018-03-28 | 2021-03-23 | Board Of Regents Of The University Of Texas System | Treating tumors using TTFields combined with a PARP inhibitor |
US11058886B1 (en) | 2018-04-05 | 2021-07-13 | Evanesc Therapeutics, Inc. | Method of polarization control of evanescent waves for treating tumors |
WO2019197973A1 (en) | 2018-04-09 | 2019-10-17 | Moshe Giladi | Treating tumors with ttfields and an aurora kinase inhibitor |
CA3096429C (en) | 2018-04-10 | 2023-10-17 | Zeev Bomzon | Low frequency (<1 mhz) ac conductivity estimates derived from two mri images having different repetition times |
BR112020025692A2 (en) | 2018-07-10 | 2021-03-16 | Novocure Gmbh | INHIBITION OF VIRAL INFECTION USING ALTERNATE ELECTRIC FIELDS |
US11179322B2 (en) | 2018-07-10 | 2021-11-23 | Novocure Gmbh | Methods and compositions for treating tumors with TTFields and sorafenib |
NZ770869A (en) | 2018-07-18 | 2023-11-24 | Novocure Gmbh | Using power loss density and related measures to quantify the dose of tumor treating fields (ttfields) |
CA3100817A1 (en) | 2018-08-23 | 2020-02-27 | Carsten Hagemann | Using alternating electric fields to increase permeability of the blood brain barrier |
US11160977B2 (en) | 2018-09-04 | 2021-11-02 | Novocure Gmbh | Delivering tumor treating fields (TTFields) to the infratentorial brain |
EP3846894A1 (en) | 2018-09-07 | 2021-07-14 | Novocure GmbH | Treating autoimmune diseases using an alternating electric field to reduce the proliferation of t-cells |
US11154707B2 (en) | 2018-10-15 | 2021-10-26 | Novocure Gmbh | Generating tumor treating fields (TTFields) with high uniformity throughout the brain |
EP3870188A1 (en) * | 2018-10-23 | 2021-09-01 | The Board of Trustees of the Leland Stanford Junior University | Prevention and treatment of teratoma formation in stem cell-based thereapies using alternating electric fields |
EP3870271A1 (en) * | 2018-10-25 | 2021-09-01 | Zeev Bomzon | Delivering alternating electric fields (e.g., ttfields) to a subject's spinal anatomy |
CN113286628A (en) * | 2018-11-01 | 2021-08-20 | 诚为本创新有限责任公司 | Apparatus and method for treating multiple tumors in a patient with metastatic disease by electric field |
EP3922300B1 (en) | 2018-11-19 | 2024-03-06 | Novocure GmbH | Arrays for delivering tumor treating fields (ttfields) with selectively addressable sub-elements |
MX2021002625A (en) | 2018-11-29 | 2021-05-12 | Novocure Gmbh | Enhanced-flexibility transducer arrays for delivering ttfields (tumor treating fields). |
JP2019093146A (en) * | 2018-12-13 | 2019-06-20 | パルティ、ヨーラム | Apparatus and methods for treating tumor with alternating electric field and for selecting treatment frequency based on estimated cell size |
CN113330485A (en) | 2019-01-08 | 2021-08-31 | 诺沃库勒有限责任公司 | Assessing the quality of segmenting an image into different types of tissue for planning a treatment using a tumor treatment field (TTField) |
JP2022519782A (en) | 2019-02-07 | 2022-03-24 | ヴィヴェーク・ケー・シャルマ | Systems and methods for treating cancer cells with alternating polar magnetic fields |
US11344740B2 (en) | 2019-02-07 | 2022-05-31 | Asha Medical, Inc. | System and methods for treating cancer cells with alternating polarity magnetic fields |
US11027143B2 (en) | 2020-02-06 | 2021-06-08 | Vivek K. Sharma | System and methods for treating cancer cells with alternating polarity magnetic fields |
WO2020174403A1 (en) * | 2019-02-26 | 2020-09-03 | Moshe Giladi | Determining a frequency for ttfields treatment based on an electrical characteristic of targeted cancer cells |
US11471676B2 (en) | 2019-02-27 | 2022-10-18 | Novocure Gmbh | Delivering tumor treating fields (TTFields) using implantable transducer arrays |
PL3946322T3 (en) | 2019-03-29 | 2024-02-26 | Novocure Gmbh | Methods for restoring sensitivity to ttfields in ttfields-resistant cancer cells with ptger3 inhibitors |
WO2020212824A1 (en) | 2019-04-17 | 2020-10-22 | Yoram Wasserman | Uploading data from an isolated system without compromising isolation |
CN110038219A (en) * | 2019-04-18 | 2019-07-23 | 马冲 | A kind of apparats for treating tumor |
US11620789B2 (en) | 2019-05-03 | 2023-04-04 | Novocure Gmbh | Methods, systems, and apparatuses for managing transducer array placement |
CN110051933A (en) * | 2019-05-31 | 2019-07-26 | 北京康源嘉成生物科技有限公司 | A kind of wearable device inhibiting pathological tissues fast-growth using electromagnetic wave |
CN114390914A (en) | 2019-08-05 | 2022-04-22 | 诺沃库勒有限责任公司 | Increasing cancer cell sensitivity to Tumor Therapy Field (TTFIELD) by inhibiting IL11 activity |
EP4021559B1 (en) | 2019-08-30 | 2023-10-25 | Novocure GmbH | Delivering tumor treating fields (ttfields) to the neck |
CN114340667A (en) | 2019-09-10 | 2022-04-12 | 诺沃库勒有限责任公司 | Method for reducing cancer cell viability by applying an alternating electric field to cancer cells and administering a checkpoint inhibitor |
US20240061398A1 (en) | 2019-10-07 | 2024-02-22 | Novocure Gmbh | Methods, systems, and apparatuses for guiding transducer array placement |
US11534601B2 (en) * | 2019-11-08 | 2022-12-27 | Novocure Gmbh | Perforated hydrogel configurations and methods of production and use thereof |
EP4134127A1 (en) | 2019-11-21 | 2023-02-15 | Novocure GmbH | Apparatus for providing tumor treating fields |
US20210162228A1 (en) | 2019-12-02 | 2021-06-03 | Novocure Gmbh | Methods, systems, and apparatuses for optimizing transducer array placement |
IL293418A (en) | 2019-12-11 | 2022-07-01 | Novocure Gmbh | Compositions and methods for imaging a cell |
EP4072657A1 (en) | 2019-12-11 | 2022-10-19 | Novocure GmbH | Methods of altering the electric impedance to an alternating electric field |
US20210178155A1 (en) | 2019-12-11 | 2021-06-17 | Novocure Gmbh | Compositions And Methods Of Altering The Electric Impedance To An Alternating Electric Field |
US20210177492A1 (en) * | 2019-12-16 | 2021-06-17 | Loyalty Based Innovations, LLC | Apparatus and method for optimizing and adapting treatment of multiple tumors in patients with metastatic disease by electric field |
CN114828955A (en) | 2019-12-20 | 2022-07-29 | 诺沃库勒有限责任公司 | Cage assembly for animal test subjects |
WO2021123910A1 (en) | 2019-12-20 | 2021-06-24 | Novocure Gmbh | Swivel assembly for actively limiting torsion of a cable, and systems and methods of using same |
US11439816B2 (en) | 2019-12-20 | 2022-09-13 | Novocure Gmbh | Treatment assembly for providing tumor treating fields to animal test subjects |
CN115243720A (en) | 2019-12-26 | 2022-10-25 | 利兰·斯坦福青年大学托管委员会 | Method for normalizing abnormal glycolytic metabolism in cancer cells |
WO2021136965A2 (en) | 2019-12-31 | 2021-07-08 | Novocure Gmbh | Methods, systems, and apparatuses for image segmentation |
US20210196967A1 (en) | 2019-12-31 | 2021-07-01 | Novocure Gmbh | Methods, systems, and apparatuses for managing temperatures induced by alternating fields |
US20210196207A1 (en) | 2019-12-31 | 2021-07-01 | Novocure Gmbh | Methods, systems, and apparatuses for associating dielectric properties with a patient model |
KR20220122679A (en) | 2019-12-31 | 2022-09-02 | 노보큐어 게엠베하 | High-voltage, high-efficiency sine wave generator that avoids spikes during switching and amplitude adjustment of channels |
US20210196943A1 (en) | 2019-12-31 | 2021-07-01 | Novocure Gmbh | Methods, systems, and apparatuses for fast approximation of electric field distribution |
US20230147250A1 (en) | 2019-12-31 | 2023-05-11 | Novocure Gmbh | Methods, systems, and apparatuses for combined tumor treating fields and mental health therapy |
CA3163316A1 (en) | 2019-12-31 | 2021-07-08 | Novocure Gmbh | Arrays for delivering tumor treating fields (ttfields) with individually accessible electrode elements and temperature sensors |
US11458298B2 (en) | 2020-01-22 | 2022-10-04 | Novocure Gmbh | Assemblies containing two conductive gel compositions and methods of production and use thereof |
WO2021198864A1 (en) | 2020-03-30 | 2021-10-07 | Novocure Gmbh | Intravenous / intra-spinal / intra-cavity / intraventricular delivery of ttfields (tumor treating fields) for treating cancer and metastases |
US20210299439A1 (en) | 2020-03-31 | 2021-09-30 | Novocure Gmb | Methods, systems, and apparatuses for guiding transducer placements for tumor treating fields |
KR102644003B1 (en) * | 2020-04-01 | 2024-03-07 | 한국전자통신연구원 | Cancer treatment device |
AU2021261745A1 (en) | 2020-04-24 | 2022-08-25 | Novocure Gmbh | Using alternating electric fields to increase permeability of the blood brain barrier |
TW202200232A (en) | 2020-05-06 | 2022-01-01 | 瑞士商諾沃庫勒有限責任公司 | Conductive pad generating tumor treating field and methods of production and use thereof |
JP2023525083A (en) | 2020-05-08 | 2023-06-14 | ノボキュア ゲーエムベーハー | Compositions and methods for applying an alternating electric field to pluripotent stem cells |
US11839771B2 (en) | 2020-06-02 | 2023-12-12 | Novocure Gmbh | Implantable arrays for providing tumor treating fields |
WO2021257967A1 (en) | 2020-06-19 | 2021-12-23 | The Methodist Hospital Dba Houston Methodist Hospital | Method and apparatus for oncomagnetic treatment |
US11818943B2 (en) | 2020-06-25 | 2023-11-14 | Novocure Gmbh | Fabricating organic light emitting diodes (OLEDs) using tubulin |
WO2022003519A2 (en) | 2020-06-29 | 2022-01-06 | Novocure Gmbh | Treating autoinflammatory and mitochondrial diseases using an alternating electric field |
TW202211946A (en) | 2020-06-30 | 2022-04-01 | 瑞士商諾沃庫勒有限責任公司 | Flexible transducer arrays with a polymer insulating layer for applying tumor treating fields (ttfields) |
CA3187793A1 (en) | 2020-08-03 | 2022-02-10 | Novocure Gmbh | Compositions and methods for increasing cancer cell sensitivity to alternating electric fields |
JP2023541542A (en) | 2020-09-18 | 2023-10-03 | ノボキュア ゲーエムベーハー | Methods and compositions for treating coronavirus |
US20220096829A1 (en) | 2020-09-30 | 2022-03-31 | Novocure Gmbh | Method and apparatus for delivering tumor treating fields to a torso, and method for determining locations for transducers to deliver tumor treating fields |
US20220096853A1 (en) | 2020-09-30 | 2022-03-31 | Novocure Gmbh | Methods and systems for transducer array placement and skin surface condition avoidance |
CN116322890A (en) | 2020-09-30 | 2023-06-23 | 诺沃库勒有限责任公司 | Implantable array for providing tumor treatment field |
TWI805954B (en) * | 2020-10-16 | 2023-06-21 | 瑞士商諾沃庫勒有限責任公司 | Applying tumor treating fields (ttfields) via electrodes embedded into skull implants |
TWI815047B (en) * | 2020-10-16 | 2023-09-11 | 瑞士商諾沃庫勒有限責任公司 | Methods for reducing viability of cancer cells by activation of the sting pathway with ttfields |
US20220148171A1 (en) | 2020-11-06 | 2022-05-12 | Novocure Gmbh | Methods and apparatuses for determining transducer locations to generate tumor treating fields |
EP4251261A1 (en) | 2020-11-25 | 2023-10-04 | Novocure Gmbh | Increasing the efficacy of tumor treating fields (ttfields) by applying the ttfields at peak intensity less than half the time |
WO2022130183A2 (en) | 2020-12-17 | 2022-06-23 | Novocure Gmbh | Pyroelectric-based temperature sensing of transducer arrays for applying tumor treating fields (ttfields) |
US11883652B2 (en) | 2020-12-21 | 2024-01-30 | Novocure Gmbh | Optimization of composite electrode |
EP4267236A2 (en) | 2020-12-24 | 2023-11-01 | Novocure GmbH | Methods and compositions for using alternating electric fields in gene therapy |
JP2024501886A (en) | 2020-12-30 | 2024-01-16 | ノボキュア ゲーエムベーハー | Amplitude modulation for tumor treatment electric fields |
CA3208097A1 (en) | 2021-01-22 | 2022-07-28 | Novocure Gmbh | Methods, systems, and apparatuses for medical image enhancement to optimize transducer array placement |
US20220241603A1 (en) | 2021-02-03 | 2022-08-04 | Novocure Gmbh | Varying Parameters of Tumor Treating Fields (TTFields) Treatment to Overcome Treatment Resistance |
KR20230150317A (en) | 2021-03-02 | 2023-10-30 | 노보큐어 게엠베하 | Method and apparatus for visualization of tumor segmentation |
WO2022190068A1 (en) | 2021-03-12 | 2022-09-15 | Novocure Gmbh | Methods of treating disease by skewing macrophage phenotype with alternating electric fields |
WO2022190067A1 (en) | 2021-03-12 | 2022-09-15 | Novocure Gmbh | Compositions and methods for using alternating electric fields to disrupt nanoparticles |
JP2024514045A (en) | 2021-03-12 | 2024-03-28 | ノボキュア ゲーエムベーハー | Electrode arrays and methods of manufacturing and using them |
JP2024515452A (en) | 2021-03-18 | 2024-04-10 | ノボキュア ゲーエムベーハー | Constructing 3D phantoms using liquid hydrogels |
WO2022201060A1 (en) | 2021-03-23 | 2022-09-29 | Novocure Gmbh | Method and apparatus for detecting and responding to changes in subjects |
JP2024510812A (en) | 2021-03-23 | 2024-03-11 | ノボキュア ゲーエムベーハー | Transducer device for delivering tumor treatment electric fields to the subject's body |
TW202241545A (en) | 2021-03-31 | 2022-11-01 | 瑞士商諾沃庫勒有限責任公司 | Carrier for elements of tumor-treating field provision system and systems and methods of using same |
US20220323753A1 (en) | 2021-04-08 | 2022-10-13 | Novocure Gmbh | Methods of Treating Neurodegenerative Disorders with Alternating Electric Fields |
CN117425515A (en) | 2021-06-01 | 2024-01-19 | 诺沃库勒有限责任公司 | Compositions and methods for treatment with a combination of alternating electric field and trastuzumab |
WO2023275648A1 (en) | 2021-06-30 | 2023-01-05 | Novocure Gmbh | Compositions and methods for using alternating electric fields to disrupt lipid capsules |
WO2023275649A1 (en) | 2021-06-30 | 2023-01-05 | Novocure Gmbh | Compositions and methods for increasing cancer cell sensitivity to alternating electric fields |
CN117813131A (en) | 2021-07-21 | 2024-04-02 | 诺沃库勒有限责任公司 | Conductive pads for generating tumor therapeutic fields and methods of producing and using the same |
KR20240045298A (en) | 2021-08-12 | 2024-04-05 | 노보큐어 게엠베하 | A transducer device having an electrode array shaped to reduce edge effects when providing a tumor treatment field to a subject's body. |
WO2023017491A1 (en) | 2021-08-12 | 2023-02-16 | Novocure Gmbh | Apparatuses for delivering tumor treating fields having electrode elements with nonuniform thicknesses and methods for manufacturing same |
KR20240045291A (en) | 2021-08-12 | 2024-04-05 | 노보큐어 게엠베하 | Method and device for delivering a tumor treatment field to a subject's body for a tumor near the surface |
KR20240045288A (en) | 2021-08-12 | 2024-04-05 | 노보큐어 게엠베하 | A transducer device with electrode element spacing to reduce edge effects when delivering a tumor treatment field to the subject's body. |
US11877838B2 (en) * | 2021-08-14 | 2024-01-23 | Nano Hesgarsazan Salamat Arya | Preventing cytokine storm in COVID-19 patients by suppressing clonal expansion in activated lymphocytes using alternating electric fields |
WO2023042080A1 (en) | 2021-09-14 | 2023-03-23 | Novocure Gmbh | Temperature independent method and system for applying ttfields |
WO2023051844A1 (en) * | 2021-09-28 | 2023-04-06 | 江苏海莱新创医疗科技有限公司 | Tumor electric field treatment system |
WO2023051845A1 (en) * | 2021-09-28 | 2023-04-06 | 江苏海莱新创医疗科技有限公司 | Tumor electric field treatment system |
WO2023051843A1 (en) * | 2021-09-28 | 2023-04-06 | 江苏海莱新创医疗科技有限公司 | Tumor electric field treatment system |
US20230102915A1 (en) | 2021-09-30 | 2023-03-30 | Novocure Gmbh | Method and system for applying tumor treating fields interfacing with hair follicles |
WO2023084340A1 (en) | 2021-11-12 | 2023-05-19 | Novocure Gmbh | Adjusting tumor treating fields simulation and treatment using molecular imaging |
US20230168242A1 (en) | 2021-11-29 | 2023-06-01 | Novocure Gmbh | Methods of Reducing Ciliogenesis with Alternating Electric Fields |
WO2023105391A1 (en) | 2021-12-07 | 2023-06-15 | Novocure Gmbh | Compact dc system for delivering a square wave ac signal |
US20230181897A1 (en) | 2021-12-10 | 2023-06-15 | Novocure Gmbh | Compression garment assembly for applying ttfields and methods of production and use thereof |
US20230173265A1 (en) | 2021-12-10 | 2023-06-08 | Novocure Gmbh | Garment providing a biasing force on a transducer array |
US20230181898A1 (en) | 2021-12-10 | 2023-06-15 | Novocure Gmbh | Compression garment assembly for applying ttfields and methods of production and use thereof |
WO2023111855A1 (en) | 2021-12-14 | 2023-06-22 | Novocure Gmbh | Shifting of transducer array to reduce skin irritation |
WO2023111847A1 (en) | 2021-12-14 | 2023-06-22 | Novocure Gmbh | Transducer array with adhesive layer shaped to reduce skin irritation |
US20230181919A1 (en) | 2021-12-14 | 2023-06-15 | Novocure Gmbh | Transducer array with shape that contours to a subject's body and method of determining shape and placement of transducer arrays |
WO2023126855A1 (en) | 2021-12-30 | 2023-07-06 | Novocure Gmbh | Selecting values of parameters for treatment using tumor treating fields (ttfields) |
WO2023180965A1 (en) | 2022-03-22 | 2023-09-28 | Novocure Gmbh | Geometrically fitted transducers for tumor treating fields |
US20230310848A1 (en) | 2022-03-30 | 2023-10-05 | Novocure Gmbh | Using Interleaved Cooling Periods to Increase the Peak Intensity of Tumor Treating Fields |
US20230310877A1 (en) * | 2022-03-30 | 2023-10-05 | Novocure Gmbh | Reducing Electrosensation Whilst Treating a Subject Using Alternating Electric Fields by Pairing Transducer Arrays Together |
WO2023187751A1 (en) | 2022-03-31 | 2023-10-05 | Novocure Gmbh | Alternating electric field waveform for electrosensation reduction |
CN114949591A (en) * | 2022-06-03 | 2022-08-30 | 江苏百宁盈创医疗科技有限公司 | TTfield therapy device capable of being adjusted regionally and using method thereof |
WO2023242741A1 (en) | 2022-06-13 | 2023-12-21 | Novocure Gmbh | Systems and methods for increasing intestinal absorption of therapeutic agents |
US20230405315A1 (en) | 2022-06-18 | 2023-12-21 | Novocure Gmbh | Compositions And Methods For Treating With A Combination Of Alternating Electric Fields And FGF Inhibitors |
WO2023248139A1 (en) | 2022-06-20 | 2023-12-28 | Novocure Gmbh | Compositions, systems, and methods for treating cancer using tumor treating fields and vegf inhibitors |
US20230407282A1 (en) | 2022-06-21 | 2023-12-21 | Novocure Gmbh | Systems and methods for treating conditions and diseases using alternating electric fields and crispr-cas system |
US20240001133A1 (en) | 2022-06-30 | 2024-01-04 | Novocure Gmbh | Tumor treating field transducers with protective border, and apparatuses and methods for active detection of improper transducer configuration |
WO2024052877A1 (en) | 2022-09-08 | 2024-03-14 | Novocure Gmbh | Constructing a 3d phantom with a matrix material having conductive particles dispersed therein |
WO2024062456A1 (en) | 2022-09-23 | 2024-03-28 | Novocure Gmbh | 3d models for predicting treatment responses to alternating electric fields |
US20240103041A1 (en) | 2022-09-27 | 2024-03-28 | Novocure Gmbh | Ingestible implantable device to measure internal ttfield intensity |
CA3180284A1 (en) | 2022-09-29 | 2024-03-29 | Novocure Gmbh | Transducer array having a temperature sensor isolation layer between a temperature sensor and external environment |
US20240108908A1 (en) | 2022-09-29 | 2024-04-04 | Novocure Gmbh | System and method for maintaining ttfields during battery changes |
WO2024069547A1 (en) | 2022-09-29 | 2024-04-04 | Novocure Gmbh | Removal of background noise from image |
WO2024069498A1 (en) | 2022-09-29 | 2024-04-04 | Novocure Gmbh | Three-dimensional model generation for tumor treating fields transducer layout |
WO2024069538A1 (en) | 2022-09-30 | 2024-04-04 | Novocure Gmbh | Compositions, systems, and methods for treating cancer using alternating electric fields and dendritic cells |
WO2024069321A1 (en) | 2022-09-30 | 2024-04-04 | Novocure Gmbh | Compositions, systems, and methods for reducing electrosensation and/or skin irritation |
WO2024069504A1 (en) | 2022-09-30 | 2024-04-04 | Novocure Gmbh | Reducing electrosensation while treating a subject using alternating electric fields by controlling ramp-up characteristics |
US20240108704A1 (en) | 2022-09-30 | 2024-04-04 | Novocure Gmbh | Compositions, systems, and methods for treating cancer using alternating electric fields and apoptotic cancer cell vaccination |
WO2024069539A1 (en) | 2022-09-30 | 2024-04-04 | Novocure Gmbh | Single wire temperature measurement solution for a ttfield application system and methods of production and use thereof |
WO2024079719A1 (en) | 2022-10-14 | 2024-04-18 | Novocure Gmbh | Method and apparatus for delivering alternating electric fields to a target tissue |
WO2024079716A1 (en) | 2022-10-14 | 2024-04-18 | Novocure Gmbh | Method and apparatus for small array dose distribution of alternating electric fields |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6043066A (en) | 1997-09-04 | 2000-03-28 | Mangano; Joseph A. | Cell separation using electric fields |
Family Cites Families (116)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR446660A (en) * | 1911-09-02 | 1912-12-12 | Gottlieb Schuettel | Device for continuous ring looms for mounting the sliders on the rings |
BE794566A (en) | 1972-01-28 | 1973-07-26 | Esb Inc | BIOELECTROCHEMICAL REGENERATOR AND STIMULATOR AND IN VIVO APPLICATION METHODS OF ELECTRIC ENERGY TO CELLS AND TISSUES. |
US3991770A (en) | 1974-01-24 | 1976-11-16 | Leveen Harry H | Method for treating benign and malignant tumors utilizing radio frequency, electromagnetic radiation |
US4016886A (en) | 1974-11-26 | 1977-04-12 | The United States Of America As Represented By The United States Energy Research And Development Administration | Method for localizing heating in tumor tissue |
US4230129A (en) * | 1975-07-11 | 1980-10-28 | Leveen Harry H | Radio frequency, electromagnetic radiation device having orbital mount |
US4119102A (en) * | 1975-07-11 | 1978-10-10 | Leveen Harry H | Radio frequency treatment of tumors while inducing hypotension |
US4121592A (en) | 1975-08-04 | 1978-10-24 | Critical Systems, Inc. | Apparatus for heating tissue |
US4154246A (en) * | 1977-07-25 | 1979-05-15 | Leveen Harry H | Field intensification in radio frequency thermotherapy |
DE2907013A1 (en) | 1978-02-24 | 1979-08-30 | American Med Syst | METHOD AND DEVICE FOR AIDING THE HEALING OF INJURED BONE CARTILES AND TISSUES IN THE FACIAL AREA |
DE2813068A1 (en) | 1978-03-25 | 1979-10-04 | Philips Patentverwaltung | METHOD AND DEVICE FOR DETERMINING INTERNAL BODY STRUCTURES |
JPS5520335A (en) * | 1978-07-28 | 1980-02-13 | Sawafuji Electric Co Ltd | Cooler |
US4263820A (en) | 1978-08-23 | 1981-04-28 | Wetherald Milo N | Energy equalizing and storing device |
GB2043453A (en) | 1979-02-22 | 1980-10-08 | Electrochem Tech Corp | Improvements in or relating to an electrode |
US4472506A (en) * | 1981-01-13 | 1984-09-18 | Liburdy Robert P | Method for determining cell membrane dielectric breakdown |
US4467809A (en) * | 1982-09-17 | 1984-08-28 | Biolectron, Inc. | Method for non-invasive electrical stimulation of epiphyseal plate growth |
US4622952A (en) | 1983-01-13 | 1986-11-18 | Gordon Robert T | Cancer treatment method |
CA1244889A (en) * | 1983-01-24 | 1988-11-15 | Kureha Chemical Ind Co Ltd | Device for hyperthermia |
DE3323415C2 (en) * | 1983-06-29 | 1985-04-25 | Kernforschungsanlage Jülich GmbH, 5170 Jülich | Use of a method and a device for the determination of cells secreting cell constituents |
EP0284608B1 (en) * | 1985-11-28 | 1990-06-20 | ZF FRIEDRICHSHAFEN Aktiengesellschaft | Mechanical remote-controlled gear-shift system |
SE455920B (en) * | 1986-01-29 | 1988-08-22 | Hans Wiksell | TUMOR HYPERTERMY TREATMENT DEVICE |
US4923814A (en) | 1986-05-09 | 1990-05-08 | Electropore, Inc. | High speed, high power apparatus for vesicle prealignment, poration, loading and fusion in uniform electric fields and method therefor |
CN86103803B (en) * | 1986-06-05 | 1987-11-18 | 北京信息工程学院 | Therapeutic equipment using electrostatic field |
JPH0511882Y2 (en) * | 1987-01-06 | 1993-03-25 | ||
US4822470A (en) | 1987-10-09 | 1989-04-18 | Baylor College Of Medicine | Method of and apparatus for cell poration and cell fusion using radiofrequency electrical pulses |
US4936303A (en) | 1987-11-20 | 1990-06-26 | Ultrathermics | Ultrasonic heating apparatus and method |
JPH0629196B2 (en) | 1987-12-01 | 1994-04-20 | 甲子郎 梅村 | Physiological action enhancer for tumor treatment by ultrasound |
US5389069A (en) | 1988-01-21 | 1995-02-14 | Massachusetts Institute Of Technology | Method and apparatus for in vivo electroporation of remote cells and tissue |
FR2627987B3 (en) | 1988-03-04 | 1990-02-02 | Indiba Sa | ELECTRONIC APPARATUS FOR MEDICAL AND COSMETIC THERAPY |
US5158071A (en) | 1988-07-01 | 1992-10-27 | Hitachi, Ltd. | Ultrasonic apparatus for therapeutical use |
GB8904998D0 (en) | 1989-03-04 | 1989-04-19 | Matthews Tony | Anaesthetising apparatus |
US5099756A (en) * | 1989-06-01 | 1992-03-31 | Harry H. Leveen | Radio frequency thermotherapy |
DE3921808A1 (en) * | 1989-07-03 | 1991-01-17 | Schubert Werner | Breaking up internal tumours using shock waves - involves gas bubbles to enhance effect in region of tumour |
US5284144A (en) * | 1989-11-22 | 1994-02-08 | The United States Of America As Represented By The Secretary Of The Dept. Of Health & Human Services | Apparatus for hyperthermia treatment of cancer |
US5441746A (en) * | 1989-12-22 | 1995-08-15 | Molecular Bioquest, Inc. | Electromagnetic wave absorbing, surface modified magnetic particles for use in medical applications, and their method of production |
SE465754B (en) * | 1990-03-05 | 1991-10-28 | Dmitry Nikolaevich Kolmakov | APPLICATOR FOR LOCAL HYPERTERMY INCLUDING A MICROWAVE RADIATION |
US5224492A (en) * | 1990-06-13 | 1993-07-06 | Omron Corporation | Thermotherapy apparatus |
US5236410A (en) | 1990-08-02 | 1993-08-17 | Ferrotherm International, Inc. | Tumor treatment method |
CA2109084C (en) * | 1991-05-03 | 2004-02-24 | John William Fisher Costerton | Biofilm reduction method |
US5441532A (en) | 1991-06-26 | 1995-08-15 | Massachusetts Institute Of Technology | Adaptive focusing and nulling hyperthermia annular and monopole phased array applicators |
US5683366A (en) * | 1992-01-07 | 1997-11-04 | Arthrocare Corporation | System and method for electrosurgical tissue canalization |
US5312513A (en) | 1992-04-03 | 1994-05-17 | Texas Instruments Incorporated | Methods of forming multiple phase light modulators |
US5412182A (en) * | 1992-04-09 | 1995-05-02 | City Of Hope | Eddy current heating for hyperthermia cancer treatment |
EP0597463A3 (en) * | 1992-11-13 | 1996-11-06 | Dornier Med Systems Inc | Thermotherapiesonde. |
US5620479A (en) * | 1992-11-13 | 1997-04-15 | The Regents Of The University Of California | Method and apparatus for thermal therapy of tumors |
US5468223A (en) | 1992-11-30 | 1995-11-21 | C.N.R.S. Paris | Electrochemotherapy |
US5386837A (en) * | 1993-02-01 | 1995-02-07 | Mmtc, Inc. | Method for enhancing delivery of chemotherapy employing high-frequency force fields |
FR2703253B1 (en) | 1993-03-30 | 1995-06-23 | Centre Nat Rech Scient | APPLICATOR OF ELECTRIC PULSES FOR TREATING BIOLOGICAL TISSUES. |
US5386069A (en) * | 1993-05-07 | 1995-01-31 | Eastman Chemical Company | Process for preparation of difluoro-tetraiodobenzene |
IL108775A (en) * | 1994-02-25 | 2003-09-17 | Univ Ramot | Method for efficient incorporation of molecules into cells |
US5704355A (en) * | 1994-07-01 | 1998-01-06 | Bridges; Jack E. | Non-invasive system for breast cancer detection |
WO1997004830A1 (en) * | 1995-07-28 | 1997-02-13 | Gray James R | Use of a polarizing field to modify the efficacy of a bioactive agent |
US5606971A (en) * | 1995-11-13 | 1997-03-04 | Artann Corporation, A Nj Corp. | Method and device for shear wave elasticity imaging |
US5718246A (en) | 1996-01-03 | 1998-02-17 | Preferential, Inc. | Preferential induction of electrically mediated cell death from applied pulses |
CA2259174C (en) * | 1996-05-31 | 2004-04-06 | Masayuki Matsuura | Low frequency therapy method, low frequency therapy apparatus and low frequency therapy system |
US5984882A (en) | 1996-08-19 | 1999-11-16 | Angiosonics Inc. | Methods for prevention and treatment of cancer and other proliferative diseases with ultrasonic energy |
US5869326A (en) | 1996-09-09 | 1999-02-09 | Genetronics, Inc. | Electroporation employing user-configured pulsing scheme |
US6027499A (en) * | 1997-05-23 | 2000-02-22 | Fiber-Tech Medical, Inc. (Assignee Of Jennifer B. Cartledge) | Method and apparatus for cryogenic spray ablation of gastrointestinal mucosa |
US6241701B1 (en) * | 1997-08-01 | 2001-06-05 | Genetronics, Inc. | Apparatus for electroporation mediated delivery of drugs and genes |
US6055453A (en) * | 1997-08-01 | 2000-04-25 | Genetronics, Inc. | Apparatus for addressing needle array electrodes for electroporation therapy |
US6497724B1 (en) * | 1999-04-30 | 2002-12-24 | The Board Of Trustees Of The Leland Stanford Junior University | Expandable space frame |
US6027488A (en) * | 1998-06-03 | 2000-02-22 | Genetronics, Inc. | Flow-through electroporation system for ex vivo gene therapy |
US5976092A (en) * | 1998-06-15 | 1999-11-02 | Chinn; Douglas O. | Combination stereotactic surgical guide and ultrasonic probe |
EP2428250A1 (en) * | 1998-07-13 | 2012-03-14 | Genetronics, Inc. | Skin and muscle-targeted gene therapy by pulsed electrical field |
EP1102608A4 (en) * | 1998-07-13 | 2008-09-17 | Genetronics Inc | Method and apparatus for electrically assisted topical delivery of agents for cosmetic applications |
US6678556B1 (en) * | 1998-07-13 | 2004-01-13 | Genetronics, Inc. | Electrical field therapy with reduced histopathological change in muscle |
US6319901B1 (en) | 1998-10-15 | 2001-11-20 | Ichor Medical Systems, Inc. | Methods for prolonging cell membrane permeability |
US6398781B1 (en) * | 1999-03-05 | 2002-06-04 | Gyrus Medical Limited | Electrosurgery system |
ATE298536T1 (en) | 1999-03-09 | 2005-07-15 | Thermage Inc | DEVICE FOR TREATING TISSUE |
US6678558B1 (en) * | 1999-03-25 | 2004-01-13 | Genetronics, Inc. | Method and apparatus for reducing electroporation-mediated muscle reaction and pain response |
US6366808B1 (en) * | 2000-03-13 | 2002-04-02 | Edward A. Schroeppel | Implantable device and method for the electrical treatment of cancer |
US6738663B2 (en) | 1999-04-09 | 2004-05-18 | Oncostim, A Minnesota Corporation | Implantable device and method for the electrical treatment of cancer |
WO2000072912A1 (en) * | 1999-05-26 | 2000-12-07 | Impulse Dynamics Nv | Local cardiac motion control using applied electrical signals and mechanical force |
US6326177B1 (en) * | 1999-08-04 | 2001-12-04 | Eastern Virginia Medical School Of The Medical College Of Hampton Roads | Method and apparatus for intracellular electro-manipulation |
US7110826B2 (en) | 2000-01-18 | 2006-09-19 | Shingo Motoi | Cosmetic use alternating current wave forms and cosmetic device |
US6853864B2 (en) | 2000-02-02 | 2005-02-08 | Catholic University Of America, The | Use of electromagnetic fields in cancer and other therapies |
US7016725B2 (en) * | 2001-11-06 | 2006-03-21 | Standen Ltd. | Method and apparatus for destroying dividing cells |
US6868289B2 (en) * | 2002-10-02 | 2005-03-15 | Standen Ltd. | Apparatus for treating a tumor or the like and articles incorporating the apparatus for treatment of the tumor |
US7146210B2 (en) | 2000-02-17 | 2006-12-05 | Standen Ltd. | Apparatus and method for optimizing tumor treatment efficiency by electric fields |
US7089054B2 (en) * | 2002-10-02 | 2006-08-08 | Standen Ltd. | Apparatus and method for treating a tumor or the like |
US7599746B2 (en) | 2000-02-17 | 2009-10-06 | Standen Ltd | Apparatus and method for preventing the spread of cancerous metastases and for elimination of metastases |
US7599745B2 (en) * | 2000-02-17 | 2009-10-06 | Standen Ltd | Treating a tumor or the like with an electric field |
US7136699B2 (en) * | 2002-10-02 | 2006-11-14 | Standen, Ltd. | Apparatus for destroying dividing cells |
US8175698B2 (en) | 2000-02-17 | 2012-05-08 | Novocure Ltd. | Treating bacteria with electric fields |
US8447395B2 (en) | 2000-02-17 | 2013-05-21 | Novocure Ltd | Treating bacteria with electric fields |
CN1416466A (en) | 2000-02-17 | 2003-05-07 | 约朗姆·帕尔蒂 | Method and appts. for destroying dividing cells |
US7565206B2 (en) | 2000-02-17 | 2009-07-21 | Standen Ltd. | Treating a tumor or the like with electric fields at different orientations |
US7465546B2 (en) * | 2000-02-23 | 2008-12-16 | The Trustees Of The University Of Pennsylvania | Regulation of transforming growth factor-beta (TGF-β) gene expression in living cells via the application of specific and selective electric and electromagnetic fields |
US6546290B1 (en) | 2000-04-12 | 2003-04-08 | Roamitron Holding S.A. | Method and apparatus for electromedical therapy |
JP3493428B2 (en) * | 2000-07-04 | 2004-02-03 | 新潟大学長 | Cancer hyperthermia treatment device |
JP3477514B2 (en) * | 2000-07-04 | 2003-12-10 | 新潟大学長 | Cancer hyperthermia treatment device |
US6466858B1 (en) * | 2000-11-02 | 2002-10-15 | General Electric Company | Methods and apparatus for monitoring gas turbine engine operation |
US6638475B1 (en) | 2000-11-08 | 2003-10-28 | The Regents Of The University Of California | Method for inhibiting pathogenic and spoilage activity in products |
CZ298160B6 (en) * | 2001-01-18 | 2007-07-11 | Apparatus for inducing an immune response in cancer therapy | |
US20020198567A1 (en) * | 2001-06-07 | 2002-12-26 | Yona Keisari | Electro-endocytotic therapy as a treatment modality of cancer |
US6994706B2 (en) * | 2001-08-13 | 2006-02-07 | Minnesota Medical Physics, Llc | Apparatus and method for treatment of benign prostatic hyperplasia |
US7130694B1 (en) * | 2001-12-26 | 2006-10-31 | Advanced Bionics Corporation | Pulse skipping strategy |
US7162303B2 (en) * | 2002-04-08 | 2007-01-09 | Ardian, Inc. | Renal nerve stimulation method and apparatus for treatment of patients |
US20040152997A1 (en) * | 2002-05-20 | 2004-08-05 | Davies Richard J. | Electrophysiological approaches to assess resection and tumor ablation margins and responses to drug therapy |
JP4152695B2 (en) | 2002-08-28 | 2008-09-17 | 株式会社アビー | Method for producing fresh frozen raw vegetables |
US6858899B2 (en) * | 2002-10-15 | 2005-02-22 | Matrix Semiconductor, Inc. | Thin film transistor with metal oxide layer and method of making same |
US6964726B2 (en) * | 2002-12-26 | 2005-11-15 | Kimberly-Clark Worldwide, Inc. | Absorbent webs including highly textured surface |
US7720549B2 (en) * | 2004-04-06 | 2010-05-18 | Oncostim, Inc. | Partially implantable system for the electrical treatment of abnormal tissue growth |
DE102004028156A1 (en) | 2004-06-09 | 2006-01-05 | Kalbe, Jochen, Dr. | Combination of radio waves and one or more of monoclonal antibodies, tyrosine-kinase inhibitors, angiogenesisi inhibitors, farnesyl transferase inhibitors, topoisomerase - I or II inhibitors, cytokine and antisense oligonucleotides |
US20060047328A1 (en) * | 2004-08-31 | 2006-03-02 | Patrick Murphy | Multi-frequency electrical field generator and use thereof |
ES2344215T3 (en) | 2004-12-07 | 2010-08-20 | Standen Ltd. | ELECTRODES TO APPLY A LIVE ELECTRIC FIELD DURING A DILATED TIME PERIOD. |
US8788044B2 (en) | 2005-01-21 | 2014-07-22 | Michael Sasha John | Systems and methods for tissue stimulation in medical treatment |
US7548780B2 (en) * | 2005-02-22 | 2009-06-16 | Cardiac Pacemakers, Inc. | Cell therapy and neural stimulation for cardiac repair |
US7853319B2 (en) * | 2005-04-21 | 2010-12-14 | Epi-Sci, Llc | Method and system for detecting electrophysiological changes in pre-cancerous and cancerous tissue and epithelium |
EP1899001B1 (en) | 2005-06-08 | 2017-10-25 | Novocure Limited | Apparatus for treating cancer with electric fields that are guided to desired locations within a body |
EP2902075B1 (en) | 2005-10-03 | 2022-11-16 | Novocure GmbH | Optimizing characteristics of an electric field to increase the field's effect on proliferating cells |
US8019414B2 (en) | 2006-04-05 | 2011-09-13 | Novocure Ltd. | Treating cancer using electromagnetic fields in combination with other treatment regimens |
US20070255320A1 (en) * | 2006-04-28 | 2007-11-01 | Cyberonics, Inc. | Method and apparatus for forming insulated implantable electrodes |
DE102006050369A1 (en) | 2006-10-25 | 2008-04-30 | Oncotherm Kft. | Hyperthermia device for the selective treatment and monitoring of surface tissue |
PT2167194T (en) | 2007-03-06 | 2017-06-15 | Novocure Ltd | Treating cancer using electromagnetic fields in combination with photodynamic therapy |
CN101820947A (en) | 2007-08-14 | 2010-09-01 | 诺沃库勒有限公司 | Use treating parasites with electric fields |
US8715203B2 (en) | 2007-09-17 | 2014-05-06 | Novocure Limited | Composite electrode |
-
2005
- 2005-04-21 US US11/111,393 patent/US7599745B2/en not_active Expired - Lifetime
- 2005-04-21 JP JP2007509012A patent/JP4750784B2/en active Active
- 2005-04-21 EP EP05767642A patent/EP1740268A2/en not_active Withdrawn
- 2005-04-21 US US11/111,423 patent/US8244345B2/en active Active
- 2005-04-21 WO PCT/IB2005/002410 patent/WO2005115535A2/en active Application Filing
- 2005-04-21 CA CA2563817A patent/CA2563817C/en active Active
- 2005-04-21 CN CN200580018206.6A patent/CN1976738B/en active Active
- 2005-04-21 US US11/111,236 patent/US7805201B2/en not_active Expired - Lifetime
- 2005-04-21 US US11/111,439 patent/US7565205B2/en not_active Expired - Lifetime
-
2010
- 2010-11-18 JP JP2010257822A patent/JP2011078804A/en active Pending
-
2012
- 2012-07-11 US US13/546,495 patent/US8706261B2/en active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6043066A (en) | 1997-09-04 | 2000-03-28 | Mangano; Joseph A. | Cell separation using electric fields |
Cited By (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8880195B2 (en) | 2007-09-14 | 2014-11-04 | Lazure Technologies, Llc | Transurethral systems and methods for ablation treatment of prostate tissue |
WO2009036468A1 (en) * | 2007-09-14 | 2009-03-19 | Lazure Technologies, Llc | Transurethral systems and methods for ablation treatment of prostate tissue |
EP3700626B1 (en) | 2017-10-23 | 2021-09-15 | Cardiac Pacemakers, Inc. | Medical devices for cancer therapy with electric field shaping elements |
WO2019084003A1 (en) * | 2017-10-23 | 2019-05-02 | Cardiac Pacemakers, Inc. | Medical devices for cancer therapy with electric field shaping elements |
US11938317B2 (en) | 2017-12-26 | 2024-03-26 | Galvanize Therapeutics, Inc. | Optimization of energy delivery for various applications |
US11730956B2 (en) | 2018-05-23 | 2023-08-22 | Ricoh Company, Ltd. | Power supply apparatus and magnetic field generation system |
EP3773877B1 (en) * | 2018-07-03 | 2024-01-17 | The Board of Trustees of the Leland Stanford Junior University | Using alternating electric fields to increase cell membrane permeability |
EP3838333B1 (en) * | 2018-07-03 | 2023-03-08 | The Board of Trustees of the Leland Stanford Junior University | Using alternating electric fields to increase cell membrane permeability |
EP3895758A1 (en) * | 2018-07-03 | 2021-10-20 | Edwin Chang | Using alternating electric fields to increase cell membrane permeability |
WO2020219339A1 (en) * | 2019-04-22 | 2020-10-29 | Boston Scientific Scimed, Inc. | Combination electrical and chemotherapeutic treatment of cancer |
US11420049B2 (en) | 2019-04-22 | 2022-08-23 | Boston Scientific Scimed, Inc. | Systems for administering electrical stimulation to treat cancer |
US11691006B2 (en) | 2019-04-22 | 2023-07-04 | Boston Scientific Scimed, Inc. | Electrical stimulation devices for cancer treatment |
WO2020219519A1 (en) * | 2019-04-23 | 2020-10-29 | Boston Scientific Scimed, Inc. | Electrodes for electrical stimulation to treat cancer |
US11607542B2 (en) | 2019-04-23 | 2023-03-21 | Boston Scientific Scimed, Inc. | Electrical stimulation for cancer treatment with internal and external electrodes |
US11712561B2 (en) | 2019-04-23 | 2023-08-01 | Boston Scientific Scimed, Inc. | Electrical stimulation with thermal treatment or thermal monitoring |
US11654279B2 (en) | 2019-07-31 | 2023-05-23 | Novocure Gmbh | Applying tumor treating fields (TTFields) via electrodes embedded into skull implants |
US11883655B2 (en) | 2020-02-24 | 2024-01-30 | Boston Scientific Scimed, Inc. | Systems and methods for treatment of pancreatic cancer |
WO2022122445A3 (en) * | 2020-12-11 | 2022-08-25 | Tdk Electronics Ag | Ceramic electrode, assembly comprising the ceramic electrode, arrangement comprising the ceramic electrode, and method for producing a ceramic electrode |
WO2022144686A1 (en) * | 2020-12-30 | 2022-07-07 | Novocure Gmbh | Method and apparatus for determining transducer locations to generate tumor treating fields |
WO2024062457A1 (en) * | 2022-09-23 | 2024-03-28 | Novocure Gmbh | Treating skin irritation from application of an alternating electric field |
Also Published As
Publication number | Publication date |
---|---|
US20050209640A1 (en) | 2005-09-22 |
JP2007533389A (en) | 2007-11-22 |
CA2563817A1 (en) | 2005-12-08 |
JP4750784B2 (en) | 2011-08-17 |
CN1976738B (en) | 2010-09-01 |
CN1976738A (en) | 2007-06-06 |
CA2563817C (en) | 2018-07-10 |
US20120283726A1 (en) | 2012-11-08 |
US20050240228A1 (en) | 2005-10-27 |
US7565205B2 (en) | 2009-07-21 |
US20050209641A1 (en) | 2005-09-22 |
US20050209642A1 (en) | 2005-09-22 |
EP1740268A2 (en) | 2007-01-10 |
US8244345B2 (en) | 2012-08-14 |
US7599745B2 (en) | 2009-10-06 |
WO2005115535A3 (en) | 2006-04-06 |
US8706261B2 (en) | 2014-04-22 |
JP2011078804A (en) | 2011-04-21 |
US7805201B2 (en) | 2010-09-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2563817C (en) | Treating a tumor or the like with electric fields at different frequencies | |
US7565206B2 (en) | Treating a tumor or the like with electric fields at different orientations | |
CA2696352C (en) | Treating parasites with electric fields | |
CA2697012C (en) | Treating bacteria with electric fields | |
US7146210B2 (en) | Apparatus and method for optimizing tumor treatment efficiency by electric fields | |
US7912540B2 (en) | Article of clothing for treating a tumor or the like | |
US7706890B2 (en) | Treating a tumor or the like with an electric field that is focused at a target region |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2563817 Country of ref document: CA Ref document number: 2007509012 Country of ref document: JP |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2005767642 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 200580018206.6 Country of ref document: CN |
|
WWP | Wipo information: published in national office |
Ref document number: 2005767642 Country of ref document: EP |